Adicet Bio, Inc.
ACET
$9.64
-$0.09-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.95% | -42.26% | -8.30% | -26.10% | -42.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.15% | -27.82% | 3.72% | -15.69% | -1.39% |
| Operating Income | 31.15% | 27.82% | -3.72% | 15.69% | 1.39% |
| Income Before Tax | 32.04% | 28.25% | -6.23% | 11.88% | -4.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.58% | 28.25% | -6.23% | 11.88% | -4.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.58% | 28.25% | -6.23% | 11.88% | -4.40% |
| EBIT | 31.15% | 27.82% | -3.72% | 15.69% | 1.39% |
| EBITDA | 31.35% | 28.28% | -4.44% | 16.42% | 1.63% |
| EPS Basic | 63.75% | 61.99% | 41.82% | 12.11% | -3.88% |
| Normalized Basic EPS | 64.00% | 61.99% | 41.82% | 12.12% | -3.88% |
| EPS Diluted | 63.75% | 61.99% | 41.82% | 12.11% | -3.88% |
| Normalized Diluted EPS | 64.00% | 61.99% | 41.82% | 12.12% | -3.88% |
| Average Basic Shares Outstanding | 88.76% | 88.77% | 82.58% | 0.26% | 0.50% |
| Average Diluted Shares Outstanding | 88.76% | 88.77% | 82.58% | 0.26% | 0.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |